Gabelli & Co Investment Advisers’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-168,600	Closed	-$6.06M	–	332
2022 Q4	$6.06M	Buy	+168,600	New	+$4.22M	1.29%	23

Gabelli & Co Investment Advisers's IMGO Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 168,600 shares — an estimated $6.06M sold.

Gabelli & Co Investment Advisers first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $6.06M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Gabelli & Co Investment Advisers reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 168,600 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $6.06M.
Gabelli & Co Investment Advisers first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Imago BioSciences, Inc. Common stock position peaked at $6.06M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.